Year archive

Novo Nordisk — 2021 filings

All 239 regulatory filings released by Novo Nordisk (NOVO) in 2021, sourced directly from the official regulator.

239 Filings

2021 Period

2021 filings (239)

Filing	Released	Lang
SC TO-T/A Filing Regulatory Filings	2021-12-28	English
SC TO-T/A Filing Regulatory Filings	2021-12-27	English
FORM 6-K Foreign Filer Report	2021-12-22	English
FORM 6-K Foreign Filer Report	2021-12-20	English
FORM 6-K Foreign Filer Report	2021-12-13	English
SC TO-T/A Filing Regulatory Filings	2021-12-08	English
FORM 6-K Foreign Filer Report	2021-12-06	English
FORM 6-K Foreign Filer Report	2021-11-30	English
FORM 6-K Foreign Filer Report	2021-11-26	English
Novo Nordisk announces impact from Volume Based Procurement for insulin in China Regulatory Filings	2021-11-26	English
Regulatory Filings 2021 Regulatory Filings	2021-11-26	English
SC TO-T Filing Regulatory Filings	2021-11-24	English
FORM 6-K Foreign Filer Report	2021-11-22	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-11-22	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-11-22	English
SC TO-C Filing Regulatory Filings	2021-11-18	English
FORM 6-K Foreign Filer Report	2021-11-15	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-11-15	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-11-15	English
FORM 6-K Foreign Filer Report	2021-11-12	English
FORM 6-K Foreign Filer Report	2021-11-12	English
Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency Regulatory Filings	2021-11-12	English
Regulatory Filings 2021 Regulatory Filings	2021-11-12	English
Wegovy™ recommended for approval for the treatment of obesity by the European regulatory authorities Regulatory Filings	2021-11-11	English
Regulatory Filings 2021 Regulatory Filings	2021-11-11	English
FORM 6-K Foreign Filer Report	2021-11-09	English
FORM 6-K Foreign Filer Report	2021-11-09	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021 Director's Dealing	2021-11-08	English
Director's Dealing 2021 Director's Dealing	2021-11-08	English
FORM 6-K Foreign Filer Report	2021-11-08	English
FORM 6-K Foreign Filer Report	2021-11-08	English
FORM 6-K Foreign Filer Report	2021-11-08	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021 Director's Dealing	2021-11-05	English
Director's Dealing 2021 Director's Dealing	2021-11-05	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-11-05	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-11-05	English
Novo Nordisk A/S purchases B shares worth DKK 4,109 million from Novo Holdings A/S under the 2021 share repurchase programme Transaction in Own Shares	2021-11-05	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-11-05	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 3 November 2021 Director's Dealing	2021-11-04	English
Director's Dealing 2021 Director's Dealing	2021-11-04	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-11-03	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-11-03	English
6-K Foreign Filer Report	2021-11-03	English
FORM 6-K Foreign Filer Report	2021-11-02	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-11-02	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-11-02	English
FORM 6-K Foreign Filer Report	2021-10-29	English
Novo Nordisk raises sales and operating profit outlook for 2021 Earnings Release 9M 2021	2021-10-29	English
Earnings Release 2021 Earnings Release 9M 2021	2021-10-29	English
FORM 6-K Foreign Filer Report	2021-10-25	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-10-25	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-10-25	English
FORM 6-K Foreign Filer Report	2021-10-18	English
FORM 6-K Foreign Filer Report	2021-10-12	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-10-11	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-10-11	English
FORM 6-K Foreign Filer Report	2021-10-05	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-10-04	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-10-04	English
FORM 6-K Foreign Filer Report	2021-09-27	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-09-27	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-09-27	English
FORM 6-K Foreign Filer Report	2021-09-20	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-09-20	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-09-20	English
FORM 6-K Foreign Filer Report	2021-09-13	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-09-13	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-09-13	English
FORM 6-K Foreign Filer Report	2021-09-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-09-06	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-09-06	English
FORM 6-K Foreign Filer Report	2021-08-30	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-08-30	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-08-30	English
FORM 6-K Foreign Filer Report	2021-08-23	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-08-23	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-08-23	English
FORM 6-K Foreign Filer Report	2021-08-16	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-08-16	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-08-16	English
FORM 6-K Foreign Filer Report	2021-08-11	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2021 Director's Dealing	2021-08-11	English
Director's Dealing 2021 Director's Dealing	2021-08-11	English
FORM 6-K Foreign Filer Report	2021-08-10	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2021 Director's Dealing	2021-08-10	English
Director's Dealing 2021 Director's Dealing	2021-08-10	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021 Director's Dealing	2021-08-09	English
Director's Dealing 2021 Director's Dealing	2021-08-09	English
6-K Foreign Filer Report	2021-08-04	English
Novo Nordisk's net profit increased by 10% in the first six months of 2021 Earnings Release H1 2021	2021-08-04	English
Earnings Release 2021 Earnings Release H1 2021	2021-08-04	English
Novo Nordisk's net profit increased by 10% in the first six months of 2021 Report Publication Announcement	2021-08-04	English
Interim / Quarterly Report 2021 Interim / Quarterly Report H1 2021	2021-08-04	English
FORM 6-K Foreign Filer Report	2021-08-04	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-08-04	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-08-04	English
FORM 6-K Foreign Filer Report	2021-07-26	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-07-26	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-07-26	English
FORM 6-K Foreign Filer Report	2021-07-19	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-07-19	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-07-19	English
FORM 6-K Foreign Filer Report	2021-07-12	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-07-12	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-07-12	English
FORM 6-K Foreign Filer Report	2021-07-06	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-07-05	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-07-05	English
Regulatory Filings 2021 Regulatory Filings	2021-06-29	English
Regulatory Filings 2021 Regulatory Filings	2021-06-29	English
FORM 6-K Foreign Filer Report	2021-06-29	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-06-28	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-28	English
FORM 6-K Foreign Filer Report	2021-06-22	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-06-21	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-21	English
FORM 6-K Foreign Filer Report	2021-06-14	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-06-14	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-14	English
FORM 6-K Foreign Filer Report	2021-06-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-06-07	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-07	English
FORM 6-K Foreign Filer Report	2021-06-07	English
Wegovy™ (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US Regulatory Filings	2021-06-04	English
Regulatory Filings 2021 Regulatory Filings	2021-06-04	English
FORM 6-K Foreign Filer Report	2021-06-01	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-05-31	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-31	English
FORM 6-K Foreign Filer Report	2021-05-29	English
FORM 6-K Foreign Filer Report	2021-05-29	English
Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval Regulatory Filings	2021-05-28	English
Regulatory Filings 2021 Regulatory Filings	2021-05-28	English
FORM SD Regulatory Filings	2021-05-27	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-05-25	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-25	English
FORM 6-K Foreign Filer Report	2021-05-18	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-05-17	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-17	English
FORM 6-K Foreign Filer Report	2021-05-10	English
FORM 6-K Foreign Filer Report	2021-05-10	English
FORM 6-K Foreign Filer Report	2021-05-10	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2021 Director's Dealing	2021-05-07	English
Director's Dealing 2021 Director's Dealing	2021-05-07	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-05-07	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-07	English
Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme Transaction in Own Shares	2021-05-07	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-07	English
6-K Foreign Filer Report	2021-05-05	English
FORM 6-K Foreign Filer Report	2021-05-04	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-04	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-05-04	English
FORM 6-K Foreign Filer Report	2021-04-29	English
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2021 Regulatory Filings	2021-04-29	English
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2021 Regulatory Filings	2021-04-29	English
FORM 6-K Foreign Filer Report	2021-04-27	English
FORM 6-K Foreign Filer Report	2021-04-27	English
Novo Nordisk A/S – Reduction of the share capital Share Issue/Capital Change	2021-04-27	English
Novo Nordisk A/S – Reduction of the share capital Share Issue/Capital Change	2021-04-27	English
FORM 6-K Foreign Filer Report	2021-04-26	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-04-26	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-04-26	English
FORM 6-K Foreign Filer Report	2021-04-21	English
Regulatory Filings 2021 Regulatory Filings	2021-04-21	English
Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide Regulatory Filings	2021-04-21	English
FORM 6-K Foreign Filer Report	2021-04-19	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-04-19	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-04-19	English
FORM 6-K Foreign Filer Report	2021-04-12	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-04-12	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-04-12	English
FORM 6-K Foreign Filer Report	2021-03-29	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-03-29	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-29	English
FORM 6-K Foreign Filer Report	2021-03-25	English
FORM 6-K Foreign Filer Report	2021-03-25	English
FORM 6-K Foreign Filer Report	2021-03-22	English
Legal Proceedings Report 2021 Legal Proceedings Report	2021-03-22	English
Novo Nordisk receives Refusal to File letter for once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes Regulatory Filings	2021-03-22	English
FORM 6-K Foreign Filer Report	2021-03-22	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-03-22	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-22	English
FORM 6-K Foreign Filer Report	2021-03-15	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-03-15	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-15	English
FORM 6-K Foreign Filer Report	2021-03-08	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-08	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-03-08	English
FORM 6-K Foreign Filer Report	2021-03-01	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-03-01	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-01	English
FORM 6-K Foreign Filer Report	2021-02-23	English
FORM 6-K Foreign Filer Report	2021-02-22	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-02-22	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-02-22	English
FORM 6-K Foreign Filer Report	2021-02-17	English
FORM 6-K Foreign Filer Report	2021-02-17	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021 Director's Dealing	2021-02-17	English
Director's Dealing 2021 Director's Dealing	2021-02-17	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021 Director's Dealing	2021-02-16	English
Director's Dealing 2021 Director's Dealing	2021-02-16	English
FORM 6-K Foreign Filer Report	2021-02-16	English
FORM 6-K Foreign Filer Report	2021-02-16	English
FORM 6-K Foreign Filer Report	2021-02-16	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-02-15	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-02-15	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021 Director's Dealing	2021-02-12	English
Director's Dealing 2021 Director's Dealing	2021-02-12	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2021 Director's Dealing	2021-02-10	English
Director's Dealing 2021 Director's Dealing	2021-02-10	English
FORM 6-K Foreign Filer Report	2021-02-08	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-02-08	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-02-08	English
FORM 6-K Foreign Filer Report	2021-02-08	English
Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021 Director's Dealing	2021-02-05	English
Director's Dealing 2021 Director's Dealing	2021-02-05	English
IRANNOTICE Regulatory Filings	2021-02-03	English
20-F Annual Report FY 2020	2021-02-03	English
6-K Foreign Filer Report	2021-02-03	English
6-K Foreign Filer Report	2021-02-03	English
6-K Foreign Filer Report	2021-02-03	English
Annual Report 2020 Annual Report FY 2020	2021-02-03	English
Earnings Release 2020 Earnings Release FY 2020	2021-02-03	English
Novo Nordisk's net profit increased by 8% in 2020 Regulatory Filings	2021-02-03	English
FORM 6-K Foreign Filer Report	2021-02-02	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-02-02	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-02-02	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-01-29	English
FORM 6-K Foreign Filer Report	2021-01-26	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-01-25	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-01-25	English
FORM 6-K Foreign Filer Report	2021-01-21	English
Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes Regulatory Filings	2021-01-20	English
Regulatory Filings 2021 Regulatory Filings	2021-01-20	English
FORM 6-K Foreign Filer Report	2021-01-19	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-01-18	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-01-18	English
FORM 6-K Foreign Filer Report	2021-01-11	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2021-01-11	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-01-11	English

Filings by year

2026 114 filings
2025 119 filings
2024 357 filings
2023 312 filings
2022 285 filings
2021 239 filings
2020 244 filings
2019 293 filings
2018 549 filings
2017 465 filings
2016 479 filings
2015 274 filings
2014 254 filings
2013 295 filings
2012 320 filings
2011 316 filings
2010 296 filings
2009 204 filings
2008 164 filings
2007 21 filings